Stay updated on Ivermectin in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Ivermectin in Severe COVID-19 Clinical Trial page.

Latest updates to the Ivermectin in Severe COVID-19 Clinical Trial page
- Check7 days agoChange DetectedThe page now shows a new revision label: v3.3.4, replacing the previous v3.3.3. There are no visible changes to study data, results, or page navigation.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.3.3 has been added; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page version was updated from v3.3.1 to v3.3.2, reflecting a minor maintenance release.SummaryDifference0.0%

- Check64 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check71 days agoChange Detected- Added comprehensive results data to the Study Results page, including Overall Number of Participants Analyzed, baseline characteristics, and multiple clinical/laboratory outcome measures and adverse events. - Also included mutation screening results and notes on exclusions due to detected mutations.SummaryDifference3%

- Check86 days agoChange DetectedNo significant changes detected in the data, outcomes, or participant characteristics; the content appears unchanged between screenshots and any differences are purely cosmetic. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ivermectin in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivermectin in Severe COVID-19 Clinical Trial page.